Gossamer Bio share price logo

Gossamer Bio

NASDAQ: GOSS

$10.71

-0.22

(-2.01%)

as on

Gossamer Bio Stock Performance

as on October 3, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $10.19
    $11.06
    downward going graph

    4.86%

    Downside

    3.27%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $9.10
    $309.60
    downward going graph

    15.00%

    Downside

    2790.76%

    Upside

    downward going graph

Gossamer Bio share price movements today

Previous Close
$10.93
Open
$10.84
Volume
330.7K
Market Cap
$66.9M
Day's Low - High
$10.19 - $11.06
52 Week Low - High
$9.10 - $309.60

Gossamer Bio Historical Returns

1 Month Return
-23.76 %
3 Month Return
-22.7 %
1 Year Return
-94.79 %
3 Year Return
-81.55 %
5 Year Return
-98.97 %

Gossamer Bio Stock Fundamentals & Key Indicators

Check Gossamer Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$66.9M

EPS (TTM)

-45.32

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.25

Industry PE ratio

-3.02

PEG Ratio

0.08

EBITDA

-205.0M

Revenue (TTM)

53.3M

Profit Margin

99.56%

Return On Equity TTM

108.75%

Gossamer Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Gossamer Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$66.9M-98.97%-0.2599.56%0.00%
StrongBuy$44.1B609.62%-23.340.00%0.00%
Neutral$75.4B-44.29%-24.08-12.57%0.00%
StrongBuy$132.5B180.98%30.1986.04%0.00%
Buy$78.1B28.80%17.6784.86%0.50%

Stock Returns calculator for Gossamer Bio Stock including INR - Dollar returns

The Gossamer Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Gossamer Bio investment value today

Current value as on today

₹5,654

Returns

-₹94,346

(-94.35%)

Returns from Gossamer Bio Stock

-₹94,791 (-94.79%)

Dollar Impact

₹445 (+0.45%)

Analyst Recommendation on Gossamer Bio Stock

Based on 3 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Gossamer Bio. Average target price of $82.48

Gossamer Bio Share Price Target

Get share price movements and forecasts by analysts on Gossamer Bio.

What analysts predicted

87.02%UPSIDE

Target Price

$82.48

Current Price

$10.71

Analyzed by

3 Analysts

High

$90

Target

$82.48

Low

$80

Gossamer Bio target price $82.48, a slight upside of 87.02% compared to current price of $10.71. According to 3 analysts rating.

Indian Investors' Interest in Gossamer Bio Stock

Search interest for Gossamer Bio Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-55% versus previous 30 day period

Gossamer Bio Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
95
9
9
9
11
13
13
16
9
Gross Profit
-
95
9
9
9
11
13
13
16
9
Operating Income
-41
52
-33
-36
-36
-38
-49
-46
-44
-26
EBITDA
-37
57
-28
-31
-33
-35
-45
-44
-43
-71
Interest Expense
3
2
2
2
2
2
2
2
2
2
Depreciation
0
0
1
1
0
0
0
0
0
0
Income Before Tax
-41
53
-31
-35
-36
-38
-48
-47
-46
16
Income Tax Expense
-
4
-1
-2
-
-
-
0
-
-
Net Income
-41
49
-30
-33
-36
-38
-48
-47
-46
16
Net Profit Margin
0.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
98.63%
100.00%

Gossamer Bio Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
114
48
Gross Profit
-
0
-3
-4
-
-
-
114
47
Operating Income
-6
-148
-186
-210
-216
-218
-183
-59
-163
EBITDA
-6
-148
-179
-226
-209
-211
-161
-39
-158
Interest Expense
0
0
-
12
19
13
13
11
10
Depreciation
1
0
3
4
5
4
4
4
1
Income Before Tax
-6
-146
-180
-243
-234
-229
-179
-55
-170
Income Tax Expense
-
-
-
-
-
-
-
0
0
Net Income
-6
-146
-180
-243
-234
-229
-179
-56
-170
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
97.93%

Gossamer Bio Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-41
49
-30
-33
-36
-38
-48
-47
-46
16
Operating Cash Flow
-52
116
-32
-35
-39
-47
-36
-48
-38
-39
Investing Cash Flow
61
-59
-26
53
22
44
17
73
41
42
Financing Cash Flow
-2
-9
0
-
0
0
1
3
0
-3
Change in Cash
6
48
-58
17
-17
-2
-17
28
3
0

Gossamer Bio Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-6
-146
-180
-243
-234
-229
-179
-56
-170
Operating Cash Flow
-5
-51
-144
-176
-188
-187
-159
-3
-171
Investing Cash Flow
-
-144
-147
215
-117
-1
-110
29
156
Financing Cash Flow
6
300
321
312
3
117
190
-11
6
Change in Cash
0
105
29
351
-303
-71
-79
13
-8

Global Institutional Holdings in Gossamer Bio

Check out the Institutions with significant holdings in Gossamer Bio.

Funds
Holdings
Joseph Edelman
51.38%
Fidelity Concord Street Trust
33.96%
Fidelity Salem Street Trust
33.49%
VANGUARD SCOTTSDALE FUNDS
18.69%
Federated Hermes Equity Funds
12.54%

Gossamer Bio News & Key Events

  • img

    Today's Timeline - 23 September

    Thu, 01:35 AM

    -

    Gossamer Bio submits first NDA to FDA for seralutinib to treat pulmonary arterial hypertension.

Insights on Gossamer Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 84.3% return, outperforming this stock by 165.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 661.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, GOSS stock has moved down by -23.8%

About Gossamer Bio

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.
OrganisationGossamer Bio
Headquarters3115 Merryfield Row, San Diego, CA, 92121, US
IndustryBiotechnology
CEOFaheem Hasnain

Key Management of Gossamer Bio

Name

Title

Ms. Jeanine Anthony

Senior Vice President of Marketing

Dr. Robert F. Roscigno Ph.D.

Senior Vice President of Clinical Development of Pulmonary Vascular Disease

Kelly Dawson

Senior Vice President & Program Team Lead

Mr. Jean-Marie Bruey Ph.D.

Senior Vice President of Translational Medicine & Research

Mr. Bryan Giraudo

COO & CFO

Mr. Robert Paul Smith Jr.

Chief Commercial Officer

Ms. Caryn L. Peterson

Chief Development Officer

Mr. Conor O'Donovan

Senior Vice President of Regulatory Affairs

Mr. Faheem Hasnain

Co-Founder, CEO, President & Chairman

Ms. Deanna Weber

Executive Vice President of Human Resources

FAQs

What is Gossamer Bio share price today?

Gossamer Bio share price today is $10.71 as on at the close of the market. Gossamer Bio share today touched a day high of $11.06 and a low of $10.19.

What is the 52 week high and 52 week low for Gossamer Bio share?

Gossamer Bio share touched a 52 week high of $309.60 on and a 52 week low of $9.10 on . Gossamer Bio stock price today i.e. is closed at $10.71,which is 96.54% down from its 52 week high and 17.64% up from its 52 week low.

What is Gossamer Bio's market capitalisation today?

Gossamer Bio market capitalisation is $0.00T as on .

How to invest in Gossamer Bio Stock (GOSS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Gossamer Bio on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Gossamer Bio Stock (GOSS) from India?

Indian investors can start investing in Gossamer Bio (GOSS) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Gossamer Bio stock (as per the Rupee-Dollar exchange rate as on ). Based on Gossamer Bio share’s latest price of $10.71 as on October 3, 2026 at 8:45 am IST, you will get 0.9337 shares of Gossamer Bio. Learn more about fractional shares .

What are the returns that Gossamer Bio has given to Indian investors in the last 5 years?

Gossamer Bio stock has given -98.97% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?